|
|
|
Case Report
|
| |
|
Intravenous pentazocine dependence in a young sickle cell anemia patient: A case report
|
|
Aishatu Yusha'u Armiya'u1,
Bilkisu Ilah Garba2,
Dalha Gwarzo Haliru3
|
1MBBS, MWACP, FMCPsych, Department of Psychiatry, Jos University Teaching Hospital, Jos. Plateau State, Nigeria.
2MBBS; Dip Allerg; MSc Med; FMCPaed, Department of Paediatrics, Yariman Bakura Specialist Hospital Gusau. Zamfara State, Nigeria.
3MBBS, FMCPath, Department of Haematology and blood transfusion, Bayero University Kano. Kano State, Nigeria.
|
Article ID: 100020CRINTAA2016
doi:10.5348/crint-2016-20-CR-1
|
Address correspondence to:
Dr Armiya'u Aishatu Yusha'u
MBBS, MWACP, FMCPsych, Department of Psychiatry
Jos University Teaching Hospital
Jos. Plateau State
Nigeria
|
Access full text article on other devices
 |
|
Access PDF of article on other devices
 |
|
|
[HTML Full Text]
[PDF Full Text]
[Print This Article]
[Similar article in Pumed]
[Similar article in Google Scholar]
|
|
How to cite this article:
|
|
Armiya'u AY, Garba BI, Haliru DG. Intravenous pentazocine dependence in a young sickle cell anemia patient: A case report. Case Rep Int 2016;5:1–4.
|
|
Introduction:
Painful crisis is the most common manifestation of sickle cell anemia (SCA), hence rapid pain control and analgesia should be provided [1][2]. Pentazocine is a narcotic agonist/antagonist analgesic commonly used in Nigeria for pain management in both medical and surgical conditions. Reports on opioid abuse/dependence amongst SCA patients are not commonly published, we report on a young SCA lady with pentazocine dependence seen at a psychiatric clinic.
Case Report:
We report a case of a 17-year-old known SCA female with a six-month history of excessive use of pentazocine. She started self-injection of pentazocine 18 months ago following a bone pain crisis and is said to have a strong desire to use the drug which she uses on daily basis. Initially, she started with 30 mg daily but currently injects 60 mg bd. She has developed hyperpigmented macules with indurations and scarification marks on both forearms. A diagnosis of pentazocine dependence with mild depression in a sickle cell anemia patient was made. She was admitted at the drug unit and managed accordingly.
Conclusion:
Health care workers should be sensitized on the dangers of analgesic abuse especially in patients with sickle cell anemia. All patients with chronic pain that require long duration of analgesic drugs should be counseled on the symptoms of dependence and informed to report immediately to their doctors.
|
Keywords:
Dependence, Pain, Pentazocine, Sickle cell anaemia
|
[HTML Full Text]
[PDF Full Text]
|
|
Author Contributions
Aishatu Yusha'u Armiya'u – Substantial contributions to conception and design, Acquisition of data, Analysis and interpretation of data, Drafting the article, Revising it critically for important intellectual content, Final approval of the version to be published
Bilkisu Ilah Garba – Analysis and interpretation of data, Revising it critically for important intellectual content, Final approval of the version to be published
Dalha Gwarzo Haliru – Analysis and interpretation of data, Revising it critically for important intellectual content, Final approval of the version to be published
|
Guarantor of submission
The corresponding author is the guarantor of submission.
|
Source of support
None
|
Conflict of interest
Authors declare no conflict of interest.
|
Copyright
©
2016 Aishatu Yusha'u Armiya'u et al. This article is distributed under the terms of Creative Commons Attribution License which permits unrestricted use, distribution and reproduction in any medium provided the original author(s) and original publisher are properly credited. Please see the copyright policy on the journal website for more information.
|
|
|
